Analysen zu Pfizer Inc.
| 31.10.23 | Pfizer Neutral | JP Morgan Chase & Co. | |
| 30.10.23 | Pfizer Buy | Jefferies & Company Inc. | |
| 20.10.23 | Pfizer Neutral | UBS AG | |
| 18.10.23 | Pfizer Neutral | UBS AG | |
| 16.10.23 | Pfizer Neutral | JP Morgan Chase & Co. | |
| 16.10.23 | Pfizer Neutral | UBS AG | |
| 16.10.23 | Pfizer Buy | Jefferies & Company Inc. | |
| 02.08.23 | Pfizer Neutral | JP Morgan Chase & Co. | |
| 01.08.23 | Pfizer Neutral | Credit Suisse Group | |
| 01.08.23 | Pfizer Hold | Jefferies & Company Inc. | |
| 01.08.23 | Pfizer Neutral | JP Morgan Chase & Co. | |
| 17.07.23 | Pfizer Neutral | JP Morgan Chase & Co. | |
| 14.07.23 | Pfizer Buy | HSBC | |
| 12.07.23 | Pfizer Neutral | Credit Suisse Group | |
| 29.06.23 | Pfizer Neutral | Credit Suisse Group | |
| 22.06.23 | Pfizer Buy | Goldman Sachs Group Inc. | |
| 01.06.23 | Pfizer Buy | Goldman Sachs Group Inc. | |
| 26.05.23 | Pfizer Hold | Jefferies & Company Inc. | |
| 25.05.23 | Pfizer Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.05.23 | Pfizer Neutral | UBS AG | |
| 03.05.23 | Pfizer Outperform | Credit Suisse Group | |
| 02.05.23 | Pfizer Hold | Jefferies & Company Inc. | |
| 02.05.23 | Pfizer Neutral | JP Morgan Chase & Co. | |
| 14.04.23 | Pfizer Outperform | Credit Suisse Group | |
| 13.04.23 | Pfizer Neutral | JP Morgan Chase & Co. | |
| 14.03.23 | Pfizer Neutral | UBS AG | |
| 06.03.23 | Pfizer Hold | Jefferies & Company Inc. | |
| 28.02.23 | Pfizer Neutral | UBS AG | |
| 27.02.23 | Pfizer Neutral | JP Morgan Chase & Co. | |
| 07.02.23 | Pfizer Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 01.02.23 | Pfizer Neutral | UBS AG | |
| 01.02.23 | Pfizer Neutral | JP Morgan Chase & Co. | |
| 31.01.23 | Pfizer Neutral | JP Morgan Chase & Co. |
Aktuelle Aktienanalysen
| 29.01.25 | DocMorris Hold | Warburg Research | |
| 29.01.25 | Continental Buy | Warburg Research | |
| 29.01.25 | Akzo Nobel Sell | Goldman Sachs Group Inc. | |
| 29.01.25 | ASML NV Overweight | JP Morgan Chase & Co. | |
| 29.01.25 | Volvo AB Buy | Goldman Sachs Group Inc. | |
| 29.01.25 | SAP Overweight | JP Morgan Chase & Co. | |
| 29.01.25 | Akzo Nobel Overweight | JP Morgan Chase & Co. | |
| 29.01.25 | Volvo AB Overweight | JP Morgan Chase & Co. | |
| 29.01.25 | ASML NV Buy | Goldman Sachs Group Inc. | |
| 29.01.25 | SAP Buy | Deutsche Bank AG | |
| 29.01.25 | RENK Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 29.01.25 | Pernod Ricard Neutral | JP Morgan Chase & Co. | |
| 29.01.25 | Sartorius Stedim Biotech Overweight | JP Morgan Chase & Co. | |
| 29.01.25 | Rheinmetall Buy | Hauck Aufhäuser Lampe Privatbank AG | |
| 29.01.25 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 29.01.25 | ASML NV Buy | Jefferies & Company Inc. | |
| 29.01.25 | Swiss Re Buy | UBS AG | |
| 29.01.25 | Münchener Rückversicherungs-Gesellschaft Neutral | UBS AG | |
| 29.01.25 | Hannover Rück Neutral | UBS AG | |
| 29.01.25 | Boeing Buy | Goldman Sachs Group Inc. | |
| 29.01.25 | LVMH Moet Hennessy Louis Vuitton Buy | Goldman Sachs Group Inc. | |
| 29.01.25 | LVMH Moet Hennessy Louis Vuitton Outperform | Bernstein Research | |
| 29.01.25 | ArcelorMittal Buy | UBS AG | |
| 29.01.25 | Sartorius Stedim Biotech Neutral | UBS AG | |
| 29.01.25 | LVMH Moet Hennessy Louis Vuitton Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 29.01.25 | Sartorius vz. Neutral | UBS AG | |
| 29.01.25 | SAP Buy | UBS AG | |
| 29.01.25 | Carl Zeiss Meditec Neutral | Goldman Sachs Group Inc. | |
| 29.01.25 | EssilorLuxottica Outperform | RBC Capital Markets | |
| 29.01.25 | Continental Buy | Jefferies & Company Inc. | |
| 29.01.25 | LVMH Moet Hennessy Louis Vuitton Overweight | Barclays Capital | |
| 29.01.25 | LVMH Moet Hennessy Louis Vuitton Neutral | JP Morgan Chase & Co. | |
| 29.01.25 | LVMH Moet Hennessy Louis Vuitton Neutral | UBS AG | |
| 28.01.25 | LVMH Moet Hennessy Louis Vuitton Hold | Jefferies & Company Inc. | |
| 28.01.25 | L'Oréal Neutral | UBS AG | |
| 28.01.25 | Continental Buy | UBS AG | |
| 28.01.25 | Pernod Ricard Neutral | JP Morgan Chase & Co. | |
| 28.01.25 | L'Oréal Underweight | JP Morgan Chase & Co. | |
| 28.01.25 | WACKER CHEMIE Kaufen | DZ BANK | |
| 28.01.25 | BMW Buy | Jefferies & Company Inc. | |
| 28.01.25 | LVMH Moet Hennessy Louis Vuitton Outperform | RBC Capital Markets | |
| 28.01.25 | Airbus Neutral | UBS AG | |
| 28.01.25 | L'Oréal Hold | Jefferies & Company Inc. | |
| 28.01.25 | Airbus Buy | Jefferies & Company Inc. | |
| 28.01.25 | Continental Overweight | JP Morgan Chase & Co. | |
| 28.01.25 | LVMH Moet Hennessy Louis Vuitton Neutral | UBS AG | |
| 28.01.25 | Nokia Overweight | JP Morgan Chase & Co. | |
| 28.01.25 | Vestas Wind Systems A-S Outperform | RBC Capital Markets | |
| 28.01.25 | Nordex Buy | Jefferies & Company Inc. | |
| 28.01.25 | Boeing Outperform | RBC Capital Markets |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.